62
Participants
Start Date
November 30, 2008
Primary Completion Date
April 30, 2012
Study Completion Date
April 30, 2012
RDEA119
Total daily doses of RDEA119 from 10 mg/day to 100 mg/day
Sorafenib
Total daily doses of sorafenib from 400 mg/day to 800 mg/day.
New York Oncology Hematology, PC, Albany
Roswell Park Cancer Institute, Buffalo
James P. Wilmot Cancer Center, Rochester
UPenn, Philadelphia
Greenville Hospital System University Medical Center, (ITOR), Greenville
Texas Oncology - Baylor Charles A. Simmons Cancer Center, Dallas
Texas Oncology-Tyler, Tyler
Comprehensive Cancer Centers of Nevada, Las Vegas
USC/Norris Comprehensive Cancer Center and LAC/USC Medical Center, Los Angeles
Toronto General Hospital, Toronto
Lead Sponsor
Bayer
INDUSTRY